We are committed to developing next-generation products that lead to better patient outcomes and are more easily distributed at home or around the world.


Vaxess Technologies is a biotechnology company headquartered in Cambridge, Massachusetts. Formed in 2012 by founders from Harvard University, the company is developing its proprietary sustained release smart delivery technologies originally developed at Tufts University and MIT.

Team

Vaxess is made up of a diverse group of scientists, engineers, and entrepreneurs. We share a passion for developing biomedical innovations that improve healthcare products and bring them to more people.

Management team

Michael Schrader
Co-founder, CEO
READ BIO

Kathryn Kosuda, PhD
Co-founder and Chief Scientific Officer
READ BIO

Livio Valenti
Co-founder, VP of Policy & Strategy
READ BIO

Jonathan Kluge, PhD
Vice President of R&D
READ BIO


Board of directors

Purnanand D Sarma
PhD
READ BIO

Kathryn Kosuda, PhD
Co-founder, VP of Research & Development
READ BIO

Michael Schrader
CEO
READ BIO

Johannes Fruehauf, MD, PhD
Co-Founder and General Partner, BioInnovation
READ BIO

Ann DeWitt

READ BIO


Advisory board

Barry Bloom, PhD
Advisor
READ BIO

David Kaplan, PhD
Scientific Co-founder, Advisor
READ BIO

Eve Slater, MD
Advisor
READ BIO

George Siber, MD
Chair, Scientific Advisory Board
READ BIO

Mark McKinlay, PhD
Advisor
READ BIO

Peter Barton Hutt, JD
Advisor
READ BIO

Russell Middaugh, PhD
Advisor
READ BIO

Thomas Monath, MD
Advisor
READ BIO

Vicki Sato, PhD
Advisor
READ BIO

Wayne Pisano
Advisor
READ BIO